Medical marijuana firm Aurora Cannabis Inc. has announced a new disclosure process for its third-party quality control testing, which it says will assure clients of the purity of its products.
That announcement comes amid growing concern over recalls of contaminated marijuana sold by Health Canada-approved producers.
Every product sold by Aurora now comes with a certificate of analysis provided by cannabis testing laboratory Anandia Labs.
Aurora, which is based in Cremona, Alta., and has offices in Vancouver, says the certificates will show that its products have "been analyzed with high accuracy for potency and passed Anandia's rigorous testing procedures for the presence of contaminants."
Latest from Cannabis Business Times
- Navigating Cultivation Room Design: Optimization vs. Maximization
- Verano Opens 18th Medical Cannabis Dispensary in Pennsylvania
- Hundreds Interested in Kentucky’s Medical Cannabis Licenses; Just 17 Apply So Far
- Aurora Receives Expanded Cultivation, Unique Research Licenses for German Facility
- Curaleaf Opening 2 New York Medical Dispensaries, Launching Adult-Use Sales at 2 Other Stores
- Ohio’s Adult-Use Licensing Process Leads CBT’s Top Stories in July
- Planet 13 Launches Lifestyles Brand Company; Signs 1st Sponsored Athlete in UFC Title Contender Chito Vera
- LeafLink Acquires Leading Cannabis Banking Platform Dama Financial